Levels of fucosylated AFP were significantly increased in HCC patients compared with those in non-HCC patients (Fig. 7B), suggesting that levels of fucosylated AFP levels can be determined using HISCL, and may be very useful biomarkers for HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.